[go: up one dir, main page]

MA28005A1 - Traitement preoperatoire de la douleur postoperatoire - Google Patents

Traitement preoperatoire de la douleur postoperatoire

Info

Publication number
MA28005A1
MA28005A1 MA28831A MA28831A MA28005A1 MA 28005 A1 MA28005 A1 MA 28005A1 MA 28831 A MA28831 A MA 28831A MA 28831 A MA28831 A MA 28831A MA 28005 A1 MA28005 A1 MA 28005A1
Authority
MA
Morocco
Prior art keywords
postoperative pain
preoperative treatment
surgery
dosage form
patient
Prior art date
Application number
MA28831A
Other languages
English (en)
Inventor
Daniel A Spyker
Bruce E Reidenberg
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MA28005A1 publication Critical patent/MA28005A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Processing Of Meat And Fish (AREA)

Abstract

On décrit un procédé pour traiter la douleur postopératoire chez un patient subissant une intervention chirurgicale. Le procédé est basé sur une administration préopératoire d'une forme de dosage transdermique contenant de la buprénorphine. La forme de dosage peut être administrée à un patient par exemple 1 à 4 jours avant l'intervention chirurgicale. Des modes de réalisation alternatifs de l'intervention concluent des formes de dosage transdermiques subséquentes pour traiter la douleur postopératoire.
MA28831A 2003-07-25 2006-02-23 Traitement preoperatoire de la douleur postoperatoire MA28005A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25

Publications (1)

Publication Number Publication Date
MA28005A1 true MA28005A1 (fr) 2006-07-03

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
MA28831A MA28005A1 (fr) 2003-07-25 2006-02-23 Traitement preoperatoire de la douleur postoperatoire

Country Status (27)

Country Link
US (3) US20080026042A1 (fr)
EP (1) EP1638492B1 (fr)
JP (1) JP5632573B2 (fr)
KR (4) KR20090031961A (fr)
CN (1) CN1829489B (fr)
AT (1) ATE382354T1 (fr)
AU (1) AU2004261181B2 (fr)
BR (1) BRPI0412924A (fr)
CA (1) CA2529983C (fr)
CY (1) CY1107352T1 (fr)
DE (1) DE602004011055T2 (fr)
DK (1) DK1638492T3 (fr)
EA (1) EA009213B1 (fr)
ES (1) ES2299871T3 (fr)
GE (1) GEP201606538B (fr)
HR (1) HRP20080146T3 (fr)
IL (1) IL173345A (fr)
IS (1) IS8186A (fr)
MA (1) MA28005A1 (fr)
MX (1) MXPA06000990A (fr)
NO (1) NO326636B1 (fr)
NZ (1) NZ594154A (fr)
PL (1) PL1638492T3 (fr)
PT (1) PT1638492E (fr)
UA (1) UA81689C2 (fr)
WO (1) WO2005011578A2 (fr)
ZA (1) ZA200510071B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
US9168251B2 (en) 2010-09-03 2015-10-27 Zoetis Belgium S.A High dose buprenorphine compositions and use as analgesic
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела
AU2023338560A1 (en) * 2022-09-09 2025-04-24 The Regents Of The University Of California Compositions for preventing transition from acute to chronic pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
KR950005865B1 (ko) * 1990-04-23 1995-06-02 데이진 가부시끼가이샤 첩부제
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (fr) * 1996-04-23 2000-07-11 Jonathan P. Wong Utilisation de ciprofloxacine encapsulee dans un liposome comme medicament immunotherapeutique
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
ES2587358T3 (es) * 2001-04-23 2016-10-24 Euro-Celtique S.A. Sistema de desecho para forma farmacéutica transdérmica
PT2062573E (pt) * 2001-05-01 2012-01-11 Euro Celtique Sa Sistemas transdérmicos que contêm opióides que resistem a violação
DE60235159D1 (de) * 2001-05-22 2010-03-11 Euro Celtique Sa Behälter und verfahren zum abgeben transdermaler dosierungsformen
US7270830B2 (en) * 2002-12-13 2007-09-18 Purdue Pharma L.P. Transdermal buprenorphine dosage regimen for analgesia

Also Published As

Publication number Publication date
ZA200510071B (en) 2006-11-29
NO326636B1 (no) 2009-01-26
KR20090031961A (ko) 2009-03-30
JP2007500133A (ja) 2007-01-11
EP1638492B1 (fr) 2008-01-02
NO20060912L (no) 2006-04-21
EP1638492A2 (fr) 2006-03-29
CA2529983C (fr) 2010-07-20
DE602004011055D1 (de) 2008-02-14
AU2004261181B2 (en) 2009-08-06
AU2004261181A1 (en) 2005-02-10
UA81689C2 (ru) 2008-01-25
CN1829489A (zh) 2006-09-06
US20140221413A1 (en) 2014-08-07
EA200600284A1 (ru) 2006-06-30
NZ594154A (en) 2012-12-21
BRPI0412924A (pt) 2006-09-26
JP5632573B2 (ja) 2014-11-26
GEP201606538B (en) 2016-09-12
IL173345A (en) 2010-06-16
IL173345A0 (en) 2006-06-11
HRP20080146T3 (en) 2008-04-30
ATE382354T1 (de) 2008-01-15
KR20080011248A (ko) 2008-01-31
PT1638492E (pt) 2008-03-17
IS8186A (is) 2005-12-19
CN1829489B (zh) 2010-12-15
US20080026042A1 (en) 2008-01-31
PL1638492T3 (pl) 2008-06-30
DK1638492T3 (da) 2008-05-13
WO2005011578A3 (fr) 2005-09-09
KR20120128715A (ko) 2012-11-27
EP1638492A4 (fr) 2006-07-19
EA009213B1 (ru) 2007-12-28
US20110002975A1 (en) 2011-01-06
KR20060054346A (ko) 2006-05-22
HK1087907A1 (en) 2006-10-27
ES2299871T3 (es) 2008-06-01
CY1107352T1 (el) 2012-12-19
MXPA06000990A (es) 2006-04-11
DE602004011055T2 (de) 2008-12-18
CA2529983A1 (fr) 2005-02-10
WO2005011578A2 (fr) 2005-02-10

Similar Documents

Publication Publication Date Title
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
CY1107262T1 (el) Θεραπεια της εξαρτησης στερησης
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
DE60320770D1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
WO2004039325A3 (fr) Compositions contenant un inhibiteur de jnk destinees a traiter, prevenir, gerer et/ou modifier la douleur, et leurs methodes d'utilisation
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
RU2423118C1 (ru) Способ лечения трофических язв
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE330600T1 (de) Kombinationspräparat zur krebstherapie
EA202191947A1 (ru) Способы лечения боли тиазолиновым противогипералгезическим средством
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
Biedermann et al. Acupuncture and myofascial pain: treatment failure after administration of tricyclic antidepressants
DE60108775T8 (de) Methode zur behandlung von schlaganfall
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne
ATE482704T1 (de) Verwendung von dopamin-rezeptor-agonisten zur behandlung von hautgeschwülsten, warzen und narben
RU2295986C2 (ru) Способ послеоперационной реабилитации
ATE403424T1 (de) Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa